Literature DB >> 27603561

Association between MDR1 gene polymorphisms and the risk of Crohn's disease in a cohort of Algerian pediatric patients.

Amira Bouzidi1, Hamida Mesbah-Amroun1, Aziza Boukercha1, Fadila Benhassine2, Réda Belboueb3, Karima Berkouk4, Wassila Messadi5, Chafia Touil-Boukoffa1.   

Abstract

BACKGROUND: The multi-drug resistance gene (MDR1) has raised increasing interest as a susceptibility gene for Crohn's disease (CD). The role of MDR1 single-nucleotide polymorphisms (SNPs) in the predisposition and behavior of CD in the pediatric population is still elusive. Here, we investigated whether SNPs in MDR1 are associated with CD in Algerian pediatric patients.
METHODS: A case-control study was conducted enrolling 47 pediatric CD patients and 100 controls. All subjects were genotyped for the most common MDR1 SNPs (C3434T, C1236T, and G2677A/T) using PCR-RFLP method. We also explored the association between polymorphisms and clinical sub-phenotypes.
RESULTS: We have detected no significant association of C3435T SNP and pediatric CD. However, we observed a significantly higher frequency of the risk alleles, 1236T and 2677T/A among the CD patients compared to controls. Moreover, the risk allele 1236T was associated to a higher risk for resective surgery.
CONCLUSION: Our data suggest that the C1236T and G2677A/T SNPs in the MDR1 gene are associated with CD and the C1236T risk allele with a more severe course of disease in Algerian pediatric patients. Further analysis using larger patients group and functional studies would be interesting to elucidate the role of MDR1 gene in pediatric CD.Pediatric Research (2016); doi:10.1038/pr.2016.163.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27603561     DOI: 10.1038/pr.2016.163

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  38 in total

Review 1.  From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation.

Authors:  Bruce E Sands
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

2.  Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study.

Authors:  Clive M Onnie; Sheila A Fisher; Reenal Pattni; Jeremy Sanderson; Alastair Forbes; Cathryn M Lewis; Christopher G Mathew
Journal:  Inflamm Bowel Dis       Date:  2006-04       Impact factor: 5.325

3.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

4.  Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients.

Authors:  O Palmieri; A Latiano; R Valvano; R D'Incà; M Vecchi; G C Sturniolo; S Saibeni; F Bossa; T Latiano; M Devoto; A Andriulli; V Annese
Journal:  Aliment Pharmacol Ther       Date:  2005-12       Impact factor: 8.171

5.  Localization of the human multiple drug resistance gene, MDR1, to 7q21.1.

Authors:  D F Callen; E Baker; R N Simmers; R Seshadri; I B Roninson
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

Review 6.  Pediatric inflammatory bowel diseases: coming of age.

Authors:  Frank M Ruemmele
Journal:  Curr Opin Gastroenterol       Date:  2010-07       Impact factor: 3.287

7.  C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.

Authors:  Maki Goto; Satohiro Masuda; Hideyuki Saito; Shinji Uemoto; Tetsuya Kiuchi; Koichi Tanaka; Ken-Ichi Inui
Journal:  Pharmacogenetics       Date:  2002-08

Review 8.  The genetics of Crohn's disease.

Authors:  Johan Van Limbergen; David C Wilson; Jack Satsangi
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

9.  Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms.

Authors:  Sarah J Hemauer; Tatiana N Nanovskaya; Sherif Z Abdel-Rahman; Svetlana L Patrikeeva; Gary D V Hankins; Mahmoud S Ahmed
Journal:  Biochem Pharmacol       Date:  2009-11-06       Impact factor: 5.858

10.  Common variants at five new loci associated with early-onset inflammatory bowel disease.

Authors:  Marcin Imielinski; Robert N Baldassano; Anne Griffiths; Richard K Russell; Vito Annese; Marla Dubinsky; Subra Kugathasan; Jonathan P Bradfield; Thomas D Walters; Patrick Sleiman; Cecilia E Kim; Aleixo Muise; Kai Wang; Joseph T Glessner; Shehzad Saeed; Haitao Zhang; Edward C Frackelton; Cuiping Hou; James H Flory; George Otieno; Rosetta M Chiavacci; Robert Grundmeier; Massimo Castro; Anna Latiano; Bruno Dallapiccola; Joanne Stempak; Debra J Abrams; Kent Taylor; Dermot McGovern; Gary Silber; Iwona Wrobel; Antonio Quiros; Jeffrey C Barrett; Sarah Hansoul; Dan L Nicolae; Judy H Cho; Richard H Duerr; John D Rioux; Steven R Brant; Mark S Silverberg; Kent D Taylor; M Michael Barmuda; Alain Bitton; Themistocles Dassopoulos; Lisa Wu Datta; Todd Green; Anne M Griffiths; Emily O Kistner; Michael T Murtha; Miguel D Regueiro; Jerome I Rotter; L Philip Schumm; A Hillary Steinhart; Stephen R Targan; Ramnik J Xavier; Cécile Libioulle; Cynthia Sandor; Mark Lathrop; Jacques Belaiche; Olivier Dewit; Ivo Gut; Simon Heath; Debby Laukens; Myriam Mni; Paul Rutgeerts; André Van Gossum; Diana Zelenika; Denis Franchimont; J P Hugot; Martine de Vos; Severine Vermeire; Edouard Louis; Lon R Cardon; Carl A Anderson; Hazel Drummond; Elaine Nimmo; Tariq Ahmad; Natalie J Prescott; Clive M Onnie; Sheila A Fisher; Jonathan Marchini; Jilur Ghori; Suzannah Bumpstead; Rhian Gwillam; Mark Tremelling; Panos Delukas; John Mansfield; Derek Jewell; Jack Satsangi; Christopher G Mathew; Miles Parkes; Michel Georges; Mark J Daly; Melvin B Heyman; George D Ferry; Barbara Kirschner; Jessica Lee; Jonah Essers; Richard Grand; Michael Stephens; Arie Levine; David Piccoli; John Van Limbergen; Salvatore Cucchiara; Dimitri S Monos; Stephen L Guthery; Lee Denson; David C Wilson; Straun F A Grant; Mark Daly; Mark S Silverberg; Jack Satsangi; Hakon Hakonarson
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

View more
  2 in total

1.  Activation of LANCL2 by BT-11 Ameliorates IBD by Supporting Regulatory T Cell Stability Through Immunometabolic Mechanisms.

Authors:  Andrew Leber; Raquel Hontecillas; Victoria Zoccoli-Rodriguez; Josep Bassaganya-Riera
Journal:  Inflamm Bowel Dis       Date:  2018-08-16       Impact factor: 5.325

2.  Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease.

Authors:  Zhenwu Lin; Zhong Wang; John P Hegarty; Tony R Lin; Yunhua Wang; Sue Deiling; Rongling Wu; Neal J Thomas; Joanna Floros
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.